About James La Rossa

This author has not yet filled in any details.
So far James La Rossa has created 176 blog entries.

Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

By |2021-11-11T17:05:32-08:00October 28th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Is dorsolateral prefrontal cortex plasticity impaired in Alzheimer disease? Yes, according to researchers writing in JAMA Psychiatry. Dorsolateral prefrontal cortex plasticity is impaired in Alzheimer disease and is associated with impaired working memory. Findings:  In this cross-sectional study of 32 participants with early Alzheimer disease and 16 healthy control participants, significant [...]

News Round-Up: Internet Porn Addiction, Suicide Attempts, Bipolar Disorder in Post-Dementia

By |2021-11-11T17:05:41-08:00October 27th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Perceived Addiction to Internet Porn Examined Perceived addiction to internet pornography appears to be related strongly to moral scruples around pornography use, both concurrently and over time, rather than with the amount of daily pornography use itself, a recent study found. Participants were adults who had used pornography within the [...]

Medworks Media and Psychopharmacology Bulletin Launch a State-of-the-Art Digital Medical Platform

By |2021-11-11T17:05:49-08:00October 26th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

October 26, 2017 www.medworksmedia.com From: Michael E. Thase, MD, Editor-in-Chief & James M. La Rossa Jr., Editorial Director & Publisher — The Most Advanced Search Engine in Psychopharmacology — Comprehensive Library of Resources — New Databases: Psychopharmacology 101 and We Know Drugs   Medworks Media and Psychopharmacology Bulletin went live [...]

Research into Hallucinogens Gives Hope to the Hopeless and Fuels a Drug Epidemic: A Tale of Two Disparate Worlds

By |2021-11-11T17:05:57-08:00October 26th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Alan F. Schatzberg, MD   Madness Rising Research into Hallucinogens Gives Hope to the Hopeless and Fuels a Drug Epidemic: A Tale of Two Disparate Worlds By James M. La Rossa Jr. Editorial Director and Publisher   In Robert Stone’s influential book about the heroin trade that permeated the Vietnam [...]

Psychopharmacology Bulletin, V47, N3: Links to In-Depth Articles

By |2021-11-11T17:06:52-08:00August 9th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Psychopharmacology Bulletin, V47, N3: Links to In-Depth Articles   ORIGINAL PRESENTATIONS   Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder. By Brianne Brown, Larry Alphs, Ibrahim Turkoz, Yong Yue   Correlation of Caregiver Burden and Baseline Characteristics of Caregivers and Patients [...]

Mental Anguish of Britain’s Prince Harry Focuses on Grief and Depression

By |2021-11-11T17:13:10-08:00April 19th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The Achilles Heel of psychiatry has always been the public's distrust of what defines a mental disorder and whether it can be treated effectively. Oftentimes, not until a trusted public person speaks up about his or her battle with a mental disorder does the public, in turn, accept the disease [...]

Smoking Cessation Drug May Boost Cognition in Schizophrenia

By |2021-11-11T17:14:20-08:00March 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]

Powerful New Chinese Opioid Intensifies Crisis: Carfentanil linked to at least 700 deaths

By |2021-11-11T17:14:28-08:00February 18th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Carfentanil, an opioid said to be 100 times more powerful than fentanyl, has been tied to at least 700 deaths in numerous states. Worst hit include Michigan, Florida, and Ohio, according to data compiled by US authorities. Carfentanil was originally intended to sedate large animals, such as elephants, and is [...]

OPINION: Recent Study Critical of Psychotropic Prescribing in the Elderly May Belie Real World Treatment

By |2021-11-11T17:14:40-08:00February 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, according to a new study published in JAMA Internal Medicine and reported in today's New York Times. The new [...]

Go to Top